Knockdown of Fra-1 led to increased chemoresistance in CSC tumors and a concurrent increase in tumor size; overexpression of Fra-1 resulted in decreased tumor incidence and in increased chemosensitivity [98]. This evidence concerns the gene FOSL1 and neoplasm.